news

news

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

Tamim Nazif

Conclusions:

  • TriGUARD 3 offers complete 3 vessel cerebral embolic protection for TAVR
  • Specific design improvements optimize safety, efficacy generalizability, and ease of use of cerebral protection
  • REFLECT Trial phase 2 is underway and expected to complete enrollment in early 2019
  • High rate of anatomic screening success based on CT Core Lab and Patient Review Committee (>90%)
No Comments

Post A Comment